Asia Pacific Allergy最新文献

{"title":"Pediatric allergies in Japan: Coronavirus disease pandemic-related risk factors.","authors":"Yuri Takaoka,&nbsp;Akihiro Maeta,&nbsp;Atsuko Nakano,&nbsp;Masaaki Hamada,&nbsp;Yukiko Hiraguchi,&nbsp;Tomoko Kawakami,&nbsp;Ikuo Okafuji,&nbsp;Yutaka Takemura,&nbsp;Makoto Kameda,&nbsp;Kyoko Takahashi,&nbsp;Shohei Akagawa,&nbsp;Kaori Anzai,&nbsp;Shinichi Sumimoto,&nbsp;Kenji Bando,&nbsp;Masaaki Doi,&nbsp;Masahiro Enomoto,&nbsp;Shiori Fujikawa,&nbsp;Akiko Ikeda,&nbsp;Megumi Nagai,&nbsp;Atsuko Nishiyama,&nbsp;Keita Otsuka,&nbsp;Satoko Shimizu,&nbsp;Yukiko Sugimoto,&nbsp;Yukiko Tanaka,&nbsp;Yuko Tanaka,&nbsp;Yuya Tanaka,&nbsp;Ryohei Wakahara,&nbsp;Koji Yamasaki","doi":"10.5415/apallergy.0000000000000116","DOIUrl":"https://doi.org/10.5415/apallergy.0000000000000116","url":null,"abstract":"<p><strong>Background: </strong>The coronavirus disease 2019 (COVID-19) pandemic impacted various parts of society, including Japanese children with allergies.</p><p><strong>Objective: </strong>This study investigated risk factors for pediatric allergic diseases associated with the state of emergency owing to the COVID-19 pandemic in Japan, including during school closures.</p><p><strong>Methods: </strong>Parents of pediatric patients (0-15 years) with allergies were enrolled and queried regarding the impact of school closure on pediatric allergies compared to that before the COVID-19 pandemic.</p><p><strong>Results: </strong>A valid response was obtained from 2302 parents; 1740 of them had children with food allergies. Approximately 4% (62/1740) of the parents reported accidental food allergen ingestion was increased compared to that before the COVID-19 pandemic. Accidental ingestion during school closures was associated with increased contact with meals containing allergens meant for siblings or other members of the family at home. The exacerbation rate during the pandemic was highest for atopic dermatitis at 13% (127/976), followed by allergic rhinitis at 8% (58/697), and bronchial asthma at 4% (27/757). The main risk factors for worsening atopic dermatitis, allergic rhinitis, and bronchial asthma were contact dermatitis of the mask area (34/120 total comments); home allergens, such as mites, dogs, and cats (15/51 total comments); and seasonal changes (6/25 total comments), respectively.</p><p><strong>Conclusion: </strong>The main factors affecting allergic diseases were likely related to increased time at home, preventive measures against COVID-19, and refraining from doctor visits. Children with allergies were affected by changes in social conditions; however, some factors, such as preventing accidental ingestion and the management of allergens at home, were similar to those before the COVID-19 pandemic. Patients who had received instructions on allergen avoidance at home before the pandemic were able to manage their disease better even when their social conditions changed.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 3","pages":"114-120"},"PeriodicalIF":1.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ba/0c/pa9-13-114.PMC10516313.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41095414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Drug-induced Stevens Johnson syndrome and toxic epidermal necrolysis: Interpreting the systematic reviews on immunomodulatory therapies.","authors":"Bernard Yu-Hor Thong","doi":"10.5415/apallergy.0000000000000101","DOIUrl":"https://doi.org/10.5415/apallergy.0000000000000101","url":null,"abstract":"<p><p>Drug-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are non-immunoglobulin E-mediated severe cutaneous adverse reactions with a high risk of morbidity, mortality, and physical and mental health impact. These are associated with certain high-risk drugs, human leukocyte antigen (HLA)-specific genotypes and ethnicities. HLA class I-restricted oligoclonal CD8 cytotoxic T-cell responses occur at the tissue level in SJS/TEN. Cytotoxic T cells are the T effector cells that result in keratinocyte apoptosis (cell death) mediated by T effector molecules granzyme B, perforin, granulysin, gamma interferon, tumor necrosis factor-alpha, and lipocalin-2. The clinical hallmarks of SJS/TEN include fever, ≥2 mucosal involvements (ocular, oral, and genital), and positive Nikolsky sign with epidermal detachment. Systematic reviews on immunomodulatory treatments remain limited by the paucity of randomized controlled trials, heterogeneity of studies, and non-standardization of outcome measures. Preventive HLA genotype screening before the prescription of carbamazepine and allopurinol may further reduce the incidence of SJS/TEN. The role of immunomodulatory treatments in SJS/TEN is at present not supported by robust evidence from systematic reviews given the lack of randomized controlled trials. The evidence for improved survival with off-label use of corticosteroids plus intravenous immunoglobulins, ciclosporin plus intravenous immunoglobulins, and ciclosporin alone has not been demonstrated by network meta-analyses and meta-regression. In the real-world clinical setting, systemic corticosteroids (in SJS and overlap SJS/TEN), ciclosporin, and etanercept (in TEN) appear to be the off-label treatments currently most widely used.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 2","pages":"72-76"},"PeriodicalIF":1.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/97/pa9-13-72.PMC10287110.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9729660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Eosinophil granule proteins as a biomarker in managing asthma and allergies.","authors":"Chang-Keun Kim,&nbsp;Zak Callaway,&nbsp;Ruby Pawankar","doi":"10.5415/apallergy.0000000000000104","DOIUrl":"https://doi.org/10.5415/apallergy.0000000000000104","url":null,"abstract":"<p><p>In the past few decades, biomarkers have been successfully used for the diagnosis, treatment, and monitoring of disease. Taking together clinical, genetic, lifestyle, and information on relevant biomarkers, the therapy of diseases can be personalized to an individual. Several novel biomarkers have been recently reported for allergic diseases. However, to interpret the validity of biomarker data, the validation of their reliability, precision, and reproducibility is imperative. Once validated, they can be used in therapeutic product development and in clinical practice. Eosinophils are multifunctional leukocytes and major effector cells that play a crucial role in the immunological mechanisms of allergic disease. Measuring eosinophils has been the gold standard for treating and monitoring eosinophil-related diseases such as asthma, atopic dermatitis, and allergic rhinitis. However, eosinophil numbers/percentages yield little information about eosinophil activity. Eosinophil activation leads to the extracellular release of 4 granule proteins, with the most promising biomarker of the 4 being eosinophil-derived neurotoxin (EDN). EDN is more easily recovered from measuring instruments and cell surfaces than other eosinophil biomarkers because of its weaker electrical charge. EDN is known to be released from eosinophils at a greater efficiency, adding to its recoverability. It also has antiviral activity in respiratory infections associated with allergic disease development in early life (eg, respiratory syncytial virus and human rhinovirus infections in early childhood). EDN can be measured in several body fluids, including blood, urine, sputum, nasal secretions, and bronchoalveolar lavage. EDN is a stable biomarker utilized to precisely diagnose, treat, and monitor many eosinophil-related allergic diseases. This eosinophil granule protein may prove useful in precision medicine approaches and should always be considered as a useful tool for the clinician to give the best patient care possible.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 2","pages":"66-71"},"PeriodicalIF":1.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/dc/pa9-13-66.PMC10287111.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9729663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Air pollution and allergy in Malaysia: The need for evidence and action.","authors":"Fatimah Ahamad, Amir Hamzah Abdul Latiff, Jemilah Mahmood","doi":"10.5415/apallergy.0000000000000105","DOIUrl":"10.5415/apallergy.0000000000000105","url":null,"abstract":"<p><p>There is a scarcity in both epidemiological studies and forecast models on the impact of air pollution on respiratory allergic responses in Malaysia. The quantification of baseline allows for an understanding of the severity of the impact and target areas for intervention. High-quality forecasts not only provide information for the assessment of potential outcomes but also the dissemination of public health warnings, such as the application of mobile-based early warning systems. There is a need for a data repository system that facilitates research on such studies. However, a call for more evidence should not put a pause on actions and future plans that will help reduce pollution emission and exposure to air pollutants as there are sufficient evidence to indicate that air pollutants impact health.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 2","pages":"85-87"},"PeriodicalIF":1.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f0/a0/pa9-13-85.PMC10287109.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9736529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The pathophysiology of postacute sequelae of COVID-19 (PASC): Possible role for persistent inflammation.","authors":"Gailen D Marshall","doi":"10.5415/apallergy.0000000000000106","DOIUrl":"10.5415/apallergy.0000000000000106","url":null,"abstract":"<p><p>As the SARS-CoV-2-induced pandemic wanes, a substantial number of patients with acute Corona Virus-induced disease (COVID-19 continue to have symptoms for a prolonged time after initial infection. These patients are said to have postacute sequelae of COVID (PASC) or \"long COVID\". The underlying pathophysiology of this syndrome is poorly understood and likely quite heterogeneous. The role of persistent, possibly deviant inflammation as a major factor in comorbidity is suspected.</p><p><strong>Objective: </strong>To review data that address the relative importance of inflammation in the pathophysiology spectrum of PASC and to address how this would impact diagnosis and approach to therapy in patients identified as having such inflammatory abnormalities.</p><p><strong>Methods: </strong>A review of public databases, including PubMed, MeSH, NLM catalog, and clinical trial databases such as clinicaltrials.gov.</p><p><strong>Results: </strong>The literature supports a prominent role for various forms and types of inflammation in the pathophysiologic spectrum of PASC. Such inflammation can be persistent ant CoV-2-specific responses, new onset autoimmune responses, or a loss of normal immunoregulation resulting in widespread, sustained inflammatory pathologies that can affect both broad constitutional symptoms (such as fatigue, neurocognitive dysfunction, and anxiety/depression) and organ-specific dysfunction and/or failure.</p><p><strong>Conclusions: </strong>PASC is a significant clinical entity with similarities to and differences from other postviral syndromes. Significant research efforts are ongoing to better understand specific aberrant inflammatory pathways present in individual patients for the purpose of developing and implementing effective therapies and ultimately prophylaxis strategies to prevent the progression of COVID-19 as well as likely future viral illnesses and pandemics.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 2","pages":"77-84"},"PeriodicalIF":1.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ac/0c/pa9-13-77.PMC10287107.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9736531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Experience of lanadelumab administration in hereditary angioedema: A case series of 4 patients in Portugal.","authors":"Ana Graça Bernardino, Manuel Branco Ferreira, Célia Costa, Joana Caiado, Elisa Pedro, Amélia Spínola Santos","doi":"10.5415/apallergy.0000000000000102","DOIUrl":"10.5415/apallergy.0000000000000102","url":null,"abstract":"Hereditary angioedema (","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 2","pages":"91-94"},"PeriodicalIF":1.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9729661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Autoimmune manifestations of CTLA-4 haploinsufficiency in two patients of Southeast Asian ethnicity.","authors":"Xin Rong Lim,&nbsp;Yi Wye Lai,&nbsp;Choon Guan Chua,&nbsp;Yen Loo Lim,&nbsp;Siong See Joyce Lee,&nbsp;Chia Wei Lim,&nbsp;Yu-Hor Bernard Thong,&nbsp;Wei-Lynn Justina Tan","doi":"10.5415/apallergy.0000000000000103","DOIUrl":"https://doi.org/10.5415/apallergy.0000000000000103","url":null,"abstract":"<p><p>We report 2 patients who first developed cutaneous manifestations, followed by autoimmune phenomena, infections, and hypogammaglobulinemia. They were initially diagnosed with common variable immunodeficiency; however, the diagnosis was revised to cytotoxic T-lymphocyte antigen 4 haploinsufficiency after genetic and functional testing.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 2","pages":"88-90"},"PeriodicalIF":1.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/69/8d/pa9-13-88.PMC10287108.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9736523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"APAAACI Allergy Week on Climate change, One Health and digital health.","authors":"Ruby Pawankar, Jiu-Yao Wang","doi":"10.5415/apallergy.0000000000000107","DOIUrl":"10.5415/apallergy.0000000000000107","url":null,"abstract":"","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 2","pages":"57-59"},"PeriodicalIF":1.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0a/ec/pa9-13-57.PMC10287106.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9736528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent.","authors":"Ankur Kumar Jindal,&nbsp;Archan Sil,&nbsp;Ridhima Aggarwal,&nbsp;Keshavamurthy Vinay,&nbsp;Anuradha Bishnoi,&nbsp;Deepti Suri,&nbsp;Amit Rawat,&nbsp;Muthu Sendhil Kumaran,&nbsp;Biman Saikia,&nbsp;Rashmi Sarkar,&nbsp;Lalit Gupta,&nbsp;D Dinesh Kumar,&nbsp;Rashmi Jindal,&nbsp;T U Sukumaran,&nbsp;Jose Ouseph,&nbsp;Hilary Longhurst,&nbsp;Ruby Pawankar,&nbsp;Surjit Singh,&nbsp;Sunil Dogra","doi":"10.5415/apallergy.0000000000000100","DOIUrl":"https://doi.org/10.5415/apallergy.0000000000000100","url":null,"abstract":"<p><p>Hereditary angioedema (HAE) is an uncommon disorder characterized clinically by recurrent episodes of nonitchy subcutaneous and/or submucosal swellings. The estimated prevalence of HAE is ~ 1: 10,000 to 1: 50,000. There are no prevalence data from India, however, estimates suggest that there are 27,000 to 135,000 patients with HAE in India at present. The majority of these, however, remain undiagnosed. Replacement of plasma-derived or recombinant C1-esterase inhibitor (C1-INH) protein, administered intravenously, is the treatment of choice during the management of acute episodes of angioedema (i.e., \"on-demand treatment\") and is also useful for short-term prophylaxis (STP) and long-term prophylaxis (LTP). This has been found to be effective and safe even in young children and during pregnancy. Until recently, none of the first-line treatment options were available for \"on-demand treatment,\" STP or LTP in India. As a result, physicians had to use fresh frozen plasma for both \"on-demand treatment\" and STP. For LTP, attenuated androgens (danazol or stanozolol) and/or tranexamic acid were commonly used. These drugs have been reported to be useful for LTP but are associated with a significant risk of adverse effects. Intravenous pd-C1-INH, the first-line treatment option, is now available in India. However, because there is no universal health insurance, access to pd-C1-INH is a significant challenge. HAE Society of India has developed these consensus guidelines for India and other resource-constrained settings where plasma-derived C1-INH therapy is the only available first-line treatment option for the management of HAE and diagnostic facilities are limited. These guidelines have been developed because it may not be possible for all patients to access the recommended therapy and at the recommended doses as suggested by the international guidelines. Moreover, it may not be feasible to follow the evaluation algorithm suggested by the international guidelines.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 2","pages":"60-65"},"PeriodicalIF":1.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/31/pa9-13-60.PMC10287105.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between prenatal and neonatal risk factors and development of bronchiolitis in early life.","authors":"Po-Sung Chen,&nbsp;Yi-Fen Tsai,&nbsp;Hong-Ren Yu,&nbsp;Chih-Hsing Hung,&nbsp;Wei-Yu Chen,&nbsp;Ching-Wei Lin,&nbsp;Ju Lee,&nbsp;Chih-An Chen,&nbsp;Hui-Ju Tsai,&nbsp;Jiu-Yao Wang","doi":"10.5415/apallergy.0000000000000002","DOIUrl":"https://doi.org/10.5415/apallergy.0000000000000002","url":null,"abstract":"<p><p>Bronchiolitis is the most common seasonal viral respiratory disorder in infants. However, risk factors for the development of bronchiolitis, particularly during pregnancy, remain unclear.</p><p><strong>Methods: </strong>A questionnaire was administered to the parents of the hospitalized infants with acute bronchiolitis to obtain information regarding patients' medical, family, and prenatal exposure history. Logistic regression with adjustment was performed to evaluate risk factors associated with bronchiolitis in the infants.</p><p><strong>Results: </strong>Among the enrolled patients, 55 (36.7%) were diagnosed as having bronchiolitis, and the majority (89%) of the patients had moderate-to-severe bronchiolitis. The bronchiolitis group had lower C-reactive protein levels than did the control group. Fewer patients in the bronchiolitis group developed fever. However, hospital stays were longer in the bronchiolitis group than in the control group. Respiratory syncytial virus was the most detected virus (23/26, 88.6%) in the bronchiolitis group. Male sex (odds ratio [OR], 5.71; 95% confidence interval [CI], 2.02-16.12; <i>P</i> < 0.001), antibiotic usage during pregnancy (OR, 27.2; 95% CI, 1.12-660.84; <i>P</i> = 0.04), and viral infection (OR, 49.3; 95% CI, 9.01-270.26; <i>P</i> < 0.001) during the postnatal period were significantly associated with hospitalization for acute bronchiolitis in the infants. By contrast, pet exposure during the perinatal period was significantly and negatively associated with acute bronchiolitis (OR = 0.21, 95% CI = 0.07-0.69, <i>P</i> < 0.01).</p><p><strong>Conclusion: </strong>Environmental exposures during pregnancy may affect respiratory health in offspring, and effective strategies should be developed to prevent bronchiolitis in early life.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"13 1","pages":"10-14"},"PeriodicalIF":1.7,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/82/df/pa9-13-10.PMC10166242.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9738086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}